FBLG
Price
$0.54
Change
-$0.02 (-3.57%)
Updated
Aug 6, 04:29 PM (EDT)
Capitalization
23.26M
SLXN
Price
$8.30
Change
-$0.56 (-6.32%)
Updated
Aug 6, 04:51 PM (EDT)
Capitalization
5.13M
Interact to see
Advertisement

FBLG vs SLXN

Header iconFBLG vs SLXN Comparison
Open Charts FBLG vs SLXNBanner chart's image
FibroBiologics
Price$0.54
Change-$0.02 (-3.57%)
Volume$100
Capitalization23.26M
Silexion Therapeutics
Price$8.30
Change-$0.56 (-6.32%)
Volume$200
Capitalization5.13M
FBLG vs SLXN Comparison Chart in %
Loading...
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBLG vs. SLXN commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLG is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (FBLG: $0.56 vs. SLXN: $8.86)
Brand notoriety: FBLG and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBLG: 153% vs. SLXN: 38%
Market capitalization -- FBLG: $23.26M vs. SLXN: $5.13M
FBLG [@Biotechnology] is valued at $23.26M. SLXN’s [@Biotechnology] market capitalization is $5.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBLG’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 1 green FA rating(s).

  • FBLG’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLXN is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBLG’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • FBLG’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FBLG is a better buy in the short-term than SLXN.

Price Growth

FBLG (@Biotechnology) experienced а -8.50% price change this week, while SLXN (@Biotechnology) price change was -28.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.86%. For the same industry, the average monthly price growth was +14.59%, and the average quarterly price growth was +13.46%.

Reported Earning Dates

FBLG is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBLG($23.3M) has a higher market cap than SLXN($5.13M). SLXN (-70.614) and FBLG (-72.235) have similar YTD gains . FBLG has higher annual earnings (EBITDA): -12.55M vs. SLXN (-16.96M). SLXN has less debt than FBLG: SLXN (3.48M) vs FBLG (10.8M). FBLG (0) and SLXN (0) have equivalent revenues.
FBLGSLXNFBLG / SLXN
Capitalization23.3M5.13M454%
EBITDA-12.55M-16.96M74%
Gain YTD-72.235-70.614102%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.85MN/A-
Total Debt10.8M3.48M310%
TECHNICAL ANALYSIS
Technical Analysis
FBLGSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
8%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
20%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 10 days ago
51%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
FBLG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFG2.940.14
+5.00%
Uni-Fuels Holdings Ltd
AMN17.490.06
+0.34%
AMN Healthcare Services
AMBO2.85N/A
-0.11%
Ambow Education Holding Ltd
AMCX5.98-0.03
-0.50%
AMC Networks
PATH11.22-0.12
-1.06%
UiPath

FBLG and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBLG has been loosely correlated with ENTO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FBLG jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
-8.74%
ENTO - FBLG
38%
Loosely correlated
-2.89%
CABA - FBLG
37%
Loosely correlated
+3.33%
TERN - FBLG
30%
Poorly correlated
+5.74%
CCCC - FBLG
30%
Poorly correlated
-4.29%
AMLX - FBLG
29%
Poorly correlated
+2.76%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-1.99%
IMA - SLXN
59%
Loosely correlated
-0.66%
CELC - SLXN
50%
Loosely correlated
-0.67%
MRSN - SLXN
43%
Loosely correlated
+2.62%
CHRS - SLXN
26%
Poorly correlated
+4.86%
QSI - SLXN
25%
Poorly correlated
N/A
More